Model Integration and Configuration for Phase I Clinical

Data Characteristics

Phase I clinical trial pharmacovigilance data primarily originates from clinical observation reports of a small number of healthy volunteers or specific patient populations. The data volume is relatively small but rich in detail. It includes subject baseline information, drug dosage, descriptions of observed Adverse Events (AEs), severity, onset time, duration, management measures, and assessment of drug-relatedness. This data typically exists in structured tables (e.g., CRF forms), semi-structured text (e.g., AE narratives), and unstructured text (e.g., handwritten doctor's notes, interview records). Data update frequency is low, mainly concentrated during the trial period and a follow-up observation period. Fields include medical terminology, dosage units (e.g., mg, μg/kg), time units (e.g., days, hours), and often medical abbreviations.

Constraints on Model Integration and Configuration

Phase I clinical data is small in volume but highly specialized, demanding that models understand medical terminology and contextual relevance. The presence of semi-structured and unstructured text necessitates more refined entity recognition, relationship extraction, and text normalization during data preprocessing. Due to the low data update frequency, frequent model training or fine-tuning is not advisable, but knowledge base maintenance must ensure the accuracy of the latest clinical guidelines and terminology. Standardization of dosage and time units is crucial; any parsing error can lead to inaccurate drug-relatedness judgments. Additionally, data sensitivity is high, requiring strict adherence to data security and privacy protection protocols for model integration, ensuring data anonymization and access control. The small sample size also affects the model's ability to identify rare adverse events, requiring enhanced recall strategies or the introduction of external medical knowledge graphs to compensate.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`Chunk size` (Segment Length)	`300–500 characters`	Phase I clinical AE descriptions are typically concise; shorter segments help preserve semantic integrity and improve recall precision.
`Chunk Overlap Length` (Segment Overlap Length)	`50 characters`	Ensures contextual continuity, preventing critical information from being truncated at segment boundaries.
`Similarity threshold` (Similarity Threshold)	`0.75–0.85`	Medical texts are highly specialized; a high threshold helps exclude irrelevant information and focus on core medical concepts.
`Recall count` (Number of Recalled Items)	`top 8–12 items`	Phase I data is relatively small; appropriately increasing the number of recalled items can improve the ability to capture potentially related information.
`PARSE_FILE_TIMEOUT_SECONDS`	`600 seconds`	Processing documents containing extensive medical terminology and complex structures can take longer; allocate sufficient time.
`maxContext`	`4096 tokens`	Ensures the model can handle a complete context including detailed AE narratives and relevant medical background information.

Common Pitfalls

Model output contains formatting errors in medical terminology or dosage units. This occurs due to insufficient standardization of specialized fields during preprocessing or the model not strictly adhering to format requirements in the prompt during generation.
The model fails to identify potential associations between adverse events and drugs in its responses. This manifests as incomplete recall results or incorrect relatedness judgments. Reasons include the knowledge base not adequately incorporating medical knowledge graphs or the similarity threshold for vector retrieval being set too high.
When integrating a locally deployed language model, tests consistently report errors. This is because the API Address or API Key in the FastGPT configuration does not correctly point to the local model's service port, or there are environmental dependency issues when the model loads.

Validation Steps

Select real-world Phase I clinical cases covering various adverse event types and complex narratives. Verify if the model can accurately identify key information and make correct drug-relatedness judgments.
Check the model's ability to parse and standardize different dosage and time units, ensuring consistency in numerical values and units in the output.
Test whether the model can accurately map medical abbreviations and synonyms to standard medical terminology, preventing information loss or misunderstanding.
Verify that after a knowledge base update, the model can promptly use the new knowledge to respond to queries, confirming the effectiveness of the knowledge base synchronization mechanism.

The values provided are common starting points and should be measured against the reader's own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.